HSGI-01-P608 - Paediatric Cardiology Programme - October 26-27, 2026

Monday, October 26, 2026, 8:00 AM - Tuesday, October 27, 2026, 3:30 PM, Sidra Medicine, Doha, Qatar


DHP Credits - Category 1 (8.25 hours), DHP Credits - Category 3 (3.00 hours), DHP Credits - Mixed Category 1 and 3 (11.25 hours), Non-Physician Participation Credit (11.25 hours)

Cardiac Anatomy and physiology, identify common congenital heart defects and their pre and postoperative management, develop assessment and monitoring skills caring for paerdiatric cardiac patients, Pharmacology management, apply evidence-based knowledge to early recognition and management of complex cardiac conditions and apply principle of family centered care.

1. upskill health care practioners to improve their knowledge on caring for paediatric cardiology patients
2. Understand Normal Cardiac anotomy and physiology.
3. Identify common congenital heart defects and their pre and post operative surgical management.
4. Develop assessment and monitoring skills caring for paediatric cardiac patients
5. Apply evidence based knowledge to identify early recognition and management of complex cardiac conditions.
6. Apply principle of family centred care

Sidra Medicine has been found to fulfill the accreditation standards and requirements and is hereby accredited as a provider for continuous medical education and professional development for healthcare practitioners (DHP), State of Qatar.

In support of improving patient care, Sidra Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Mitigation of Relevant Financial Relationships

Sidra Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.